THE STUDy OF THE NEUROPSyCHOPHARMACOLOGICAL EFFECTS OF THE NEW DERIVATIVE OF GLUTAMIC ACID, THE RGPU-197 COMPOUND
- Authors: Bagmetova VV1, Bagmetov MN1, Tyurenkov I.N.1, Vasilieva ОS2, Berestovitskaya VМ2
-
Affiliations:
- The Volgograd State Medical University
- Herzen State Pedagogical University of Russia
- Issue: Vol 10, No 1 (2012)
- Pages: 54-59
- Section: Articles
- Submitted: 27.07.2016
- Published: 15.03.2012
- URL: https://journals.eco-vector.com/RCF/article/view/3610
- DOI: https://doi.org/10.17816/RCF10154-59
- ID: 3610
Cite item
Abstract
Proceeding from the proposition about the high productivity of the search of neuropsychotropic substances among the derivatives of natural neuromediators, a study of neuropsychopharmacological effects of the derivative of the glutamic acid, RGPU-197 compound was carried out. The study was carried out on the he-rats of the Wistar line using the following tests: “open field”, elevated plus maze, conditioned passive-avoidance response, the test of extrapolational deliverance, the test of hanging mice by tails; and also the methods of statistic analysis: rank univariate analysis of Cruscal-Wallace, the Dunn multiple comparison test /the multiple comparison test of Dunn, the x2 criterion. The RGPU-197 compound significantly (p<0,05, p<0,01) decreases the duration of immobilization of the animals and expands the latent period of its approach in the test of hanging mice by tails — it possesses antidepressant activity; increases the quantity of the visits of the centre of the open field, the quantity of attendings of the open hoses of elevated plus maze and the time of stay in them — it shows anxiolytic action; increases the quantity of crossed squares in the open field and the quantity of crossings between the hoses of elevated plus maze — it possesses activating effect; during the displays of the avoidance reflex it expands the latent period of the first period of entering the dark compartment and the quantity of enterings of it in conditioned passive-avoidance response, reduces the latent period of diving under in the test of extrapolational deliverance — it shows nootropic action. According to the intensity of antidepressant action RGPU-197 doesn’t yield to melipramin, anxiolytic and activating effects significantly (p<0.05) excels phenibutum and doesn’t yield to it by nootropic activity. Thus, the new derivative of glutamate, the RGPU-197 compound, possesses the marked antidepressant, anxiolytic and activating effects, as well as nootropic activity.
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
V V Bagmetova
The Volgograd State Medical University
Email: info@volgmed.ru
M N Bagmetov
The Volgograd State Medical University
Email: info@volgmed.ru
Ivan Nikolaevich Tyurenkov
The Volgograd State Medical University
Email: info@volgmed.ru
О S Vasilieva
Herzen State Pedagogical University of Russia
V М Berestovitskaya
Herzen State Pedagogical University of Russia
References
- Арушанян Э. Б. Нейрохимическая природа лекарственной психостимуляции: взгляд на проблему четверть века спустя // Эксперим. и клинич. фармакология. — 2003. — Т. 66, № 2. — С. 72–80.
- Бондаренко Н. А., Плескачева М. Г., Бондаренко Ник. А. Формы поведения в водном тесте «экстраполяционного избавления» у крыс разных линий Териофауна России и сопредельных территорий (VII съезд Териологического общества): матер. междунар. совещ. — Москва, 2003. — С.51–60.
- Воронина Т. А. Роль синаптической передачи в процессах памяти, нейродегенерации и механизме действия нейротропных препаратов // Эксперим. и клинич. фармакология. — 2003. — Т. 66, №2. — С.10–14.
- Зорина З. А., Полетаева И. И., Резникова Ж. И. Основы этологии и генетики поведения. 2-е изд. // — М.: Изд-во МГУ «Высшая школа», 2002. — 384 с.
- Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. 2-е изд., перераб. и доп. // Под ред. Р. У. Хабриева. — М.: Медицина, 2005. — 832 с.
- Петров В. И., Пиотровский Л. Б., Григорьев И. А. Возбуждающие аминокислоты (нейрохимия, фармакология и терапевтический потенциал ВАКергических средств) — Волгоград: ВМА, 1997. — 167с.
- Петров В. И., Н. В. Онищенко Современные направления исследований и клинического применения глутаматергических средств // Эксперим. и клинич. фармакология. — 2002. — Т. 65, № 4. — С. 66–70.
- Петров В. И. Создание и фармакология ноотропных и антидепрессивных препаратов на основе лигандов ВАК-рецепторов // Эксперим. и клинич. фармакология. — 2003. — Т.66, №2. — С.20–23.
- Пошивалов В. П. Фармакоэтология // Усп. совр. биол., 1985. — Т. 99, Вып. 3. — С. 463–478.
- Citow J. S., Macdonald R. L. Neuroanatomy and Neurophysiolog y: A Review in 2 vs., Vol. 2 /. PhD. — New York: Stuttgart Thieme, 2001. — 239 p.
![](/img/style/loading.gif)